Publications of the Week Endomembrane Targeting of Human OAS1 p46 Augments Antiviral Activity Soveg, F., et al. | August 23, 2021 Lead authors Frank Soveg and Johannes Schwerk identified a membrane-targeted gene, OAS1 p46, with strong…dcorriganAugust 23, 2021 Read More
Publications of the Week The Redox-Responsive Transcriptional Regulator Rex Represses Fermentative Metabolism and Is Required for Listeria monocytogenes Pathogenesis Halsey, C., et al. | August 20, 2021 In this work, we characterized the role of the redox-responsive transcriptional regulator Rex in Listeria…dcorriganAugust 20, 2021 Read More
Publications of the Week Massively Parallel Characterization of CYP2C9 Variant Enzyme Activity and Abundance Amorosi, C., et al. | August 20, 2021 Scientists only have accurate dosage advice for a small number of the most well-studied genetic…dcorriganAugust 20, 2021 Read More
Publications of the Week A Subpopulation of Microglia Generated in the Adult Mouse Brain Originate from Prominin-1 Expressing Progenitors Prater, K., et. al | August 19, 2021 Microglia maintain brain health and play important roles in disease and injury. Despite their known…dcorriganAugust 19, 2021 Read More
Local News Aptevo Therapeutics Announces APVO436 Monotherapy Is Active in Patients Who Have Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Aptevo Therapeutics | August 18, 2021 Aptevo Therapeutics Inc., a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on…dcorriganAugust 18, 2021 Read More
Local News HDT Bio Announces Agreement with Korea’s Quratis to Co-Develop Innovative COVID-19 Vaccine in Asia HDT Bio Corporation | August 17, 2021 HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an…dcorriganAugust 17, 2021 Read More
Local News Just – Evotec Biologics Opens J.POD® 1 US in Redmond, Washington Life Science Washington | August 17, 2021 Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing…dcorriganAugust 17, 2021 Read More
Local News GentiBio Nets $157 Million to Restore Immune Tolerance with Tregs BioSpace | August 16, 2021 GentiBio is developing engineered regulatory T cells (Tregs) to build a better immune system and…dcorriganAugust 16, 2021 Read More
Awards Two Fred Hutch Postdocs Named 2021 Damon Runyon Fellows Fred Hutch | August 16, 2021 Two postdoctoral researchers at Fred Hutchinson Cancer Research Center are among the 17 early career…dcorriganAugust 16, 2021 Read More
Publications of the Week Antibody Interference by a Non-Neutralizing Antibody Abrogates Humoral Protection against Plasmodium yoelii Liver Stage Vijayan, K., et al. | August 13, 2021 Most work on the development of malaria vaccines happens in laboratory or clinical trials, where…dcorriganAugust 13, 2021 Read More